[1] JACC 2022 Source:Heidenreich P, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol 2022; 79: e263−e421. doi: 10.1016/j.jacc.2021.12.012 [2] Kittleson MM, Shah P, Lala A, et al. INTERMACS profiles and outcomes of ambulatory advanced heart failure patients: A report from the REVIVAL Registry. J Heart Lung Transplant 2020; 39: 16−26. doi: 10.1016/j.healun.2019.08.017 [3]

Allen JG, Kilic A, Weiss ES, et al. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices? Ann Thorac Surg 2012; 94: 2017-2024.

[4]

Kilic A, Acker MA, Atluri P. Dealing with surgical left ventricular assist device complications. J Thorac Dis 2015; 7: 2158−2164.

[5] Siems C, Cogswell R, Masotti M, et al. Impact of left ventricular assist device complications on heart transplant outcomes under the 2018 heart transplant allocation policy. J Thorac Cardiovasc Surg 2022. Published Online First: September 27, 2022. DOI: 10.1016/j.jtcvs.2022.08.052. [6]

Liu J, Yang BQ, Itoh A, et al. Impact of New UNOS allocation criteria on heart transplant practices and outcomes. Transplant Direct 2020; 7: e642.

[7] Lala A, Rowland JC, Ferket BS, et al. Strategies of wait-listing for heart transplant vs durable mechanical circulatory support alone for patients with advanced heart failure. JAMA Cardiol 2020; 5: 652−659. doi: 10.1001/jamacardio.2020.0631 [8] Borkon AM, Muehlebach GF, Jones PG, et al. An analysis of the effect of age on survival after heart transplant. J Heart Lung Transplant 1999; 18: 668−674. doi: 10.1016/S1053-2498(99)00024-8 [9]

Liu J, Yang BQ, Itoh A, et al. Impact of New UNOS allocation criteria on heart transplant practices and outcomes. Transplant Direct 2020; 7: e642.

[10]

Paghdar S, Desai S, Ruiz J, et al. Malposition of impella 5.5 during physical therapy in a patient awaiting heart transplant. J Am Coll Cardiol 2023, 81 (8_Supplement) 3544.

[11] Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: 480−486. doi: 10.1161/CIRCULATIONAHA.108.191259 [12] Mozaffarian D, Benjamin EJ, Go AS. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 2015; 131: e29−e322. doi: 10.1161/circ.131.suppl_2.o29 [13] Hertz MI, Taylor DO, Trulock EP, et al. The registry of the international society for heart and lung transplantation: nineteenth official report-2002. J Heart Lung Transplant 2002; 21: 950−970. doi: 10.1016/S1053-2498(02)00498-9 [14] Miller, Leslie W. Listing criteria for cardiac transplantation: results of an American Society of Transplant Physicians-National Institutes of Health conference. Transplantation 1998; 66: 947−951. doi: 10.1097/00007890-199810150-00032 [15]

Akintoye E, Alvarez P, Shin D, et al. Changing demographics, temporal trends in waitlist, and posttransplant outcomes after heart transplantation in the United States: Analysis of the UNOS Database 1991–2019. Circ Heart Fail 2021; 14: e008764.

[16] Tjang YS, van der Heijden GJ, Tenderich G, et al. Impact of recipient’s age on heart transplantation outcome. Ann Thorac Surg 2008; 85: 2051−2055. doi: 10.1016/j.athoracsur.2008.02.015 [17] [18] Siddiqi TJ, Minhas AMK, Greene SJ, et al. Trends in heart failure-related mortality among older adults in the United States From 1999-2019. JACC Heart Fail 2022; 10: 851−859. doi: 10.1016/j.jchf.2022.06.012 [19] Rushakoff JA, Kransdorf EP. Heart Transplant in Older Adults. Curr Transplant Rep 2022; 9: 48−54. doi: 10.1007/s40472-022-00358-1 [20] Jaiswal A, Gadela NV, Baran D, et al. Clinical outcomes of older adults listed for heart transplantation in the United States. J Am Geriatr Soc 2021; 69: 2507−2517. doi: 10.1111/jgs.17271 [21] Demers P, Moffatt S, Oyer PE, et al. Long-term results of heart transplantation in patients older than 60 years. J Thorac Cardiovasc Surg 2003; 126: 224−231. doi: 10.1016/S0022-5223(03)00055-2 [22]

Jang JM, Nativi J, Patel P, et al. REN3: percutaneous axillary temporary mechanical support improves renal function prior to heart transplantation in patients with chronic kidney disease. ASAIO J 2022; 68: 89.

[23]

Malkani S, Desai S, Ruiz J, et al. Risk of thrombocytopenia due to the interaction of systemic anticoagulation and impella purge solution in patients with temporary mechanical circulatory support. J Am Coll Cardiol 2023; 81(8_Supplement): 577.

[24]

O’Connell G, Wang AS, Kurlansky P, et al. Impact of UNOS allocation policy changes on utilization and outcomes of patients bridged to heart transplant with intra-aortic balloon pump. Clin Transplant 2022; 36: e14533.

[25] Hanff TC, Harhay MO, Kimmel SE, et al. Trends in mechanical support use as a bridge to adult heart transplant under new allocation rules. JAMA Cardiol 2020; 5: 728−729. doi: 10.1001/jamacardio.2020.0667 [26]

Lam K, Sjauw KD, van der Meulen J, et al. A combined surgical and percutaneous approach through the axillary artery to introduce the Impella LP5.0 for short-term circulatory support. Int J Cardiol 2009; 134: 277−279.

[27] Nishida H, Song T, Onsager D, et al. Significant vascular complications in percutaneous axillary intra-aortic balloon pump. Ann Vasc Surg 2022; 83: 42−52. doi: 10.1016/j.avsg.2021.12.078 [28]

Malkani S, Ruiz J, Desai S, et al. Migration of intra-aortic balloon pump causing obstruction of the superior mesenteric artery. J Geriatr Cardiol 2022; 19: 928−929.

[29]

Haddad O, Jacob S, Ung RL, et al. Impella flow pump reinsertion after axillary graft thrombectomy: Technical points in replacing axillary Impella. SAGE Open Med Case Rep 2021; 9: 2050313X211032401.